P2Y13 receptor is critical for reverse cholesterol transport
about
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionImportant roles of P2Y receptors in the inflammation and cancer of digestive systemLiver X receptors at the intersection of lipid metabolism and atherogenesisReduced bone turnover in mice lacking the P2Y13 receptor of ADP.Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport.Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterolExtracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.Transcriptome analysis of genes regulated by cholesterol loading in two strains of mouse macrophages associates lysosome pathway and ER stress response with atherosclerosis susceptibilityMacrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization.The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss.P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivoBile acids reduce endocytosis of high-density lipoprotein (HDL) in HepG2 cells.Purines as potential morphogens during embryonic development.Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES StudyP2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elementsTachometer for reverse cholesterol transport?Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.HDL and endothelial protection.Acute stress show great influences on liver function and the expression of hepatic genes associated with lipid metabolism in rats.Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.HDL endocytosis and resecretionAssessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.Purinergic signalling in the liver in health and disease.An integrated approach for the mechanisms responsible for atherosclerotic plaque regressionRecombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA.Role of the ubiquitin-proteasome system in the regulation of P2Y13 receptor expression: impact on hepatic HDL uptake.An Update on P2Y13 Receptor Signalling and Function.Disruption of the Microglial ADP Receptor P2Y13 Enhances Adult Hippocampal Neurogenesis.
P2860
Q26865600-7F25FB28-4AB0-4D56-8375-FAA2689634F8Q26991904-2107D09F-B47C-402F-B8AD-207FB53EC292Q28082452-93D089A8-7AE0-4374-87A9-6C7AEC2A66A3Q33636713-A41DE00A-C8D9-4FF8-AAA9-BDF3B5181DECQ33642949-28A30F65-0D5A-4902-A2B8-AAF3114E0FDEQ34025964-78F17110-80CE-4440-A39B-F25638D57D6AQ34271095-9989AA7D-DF7E-48F9-B735-67A8022BECEFQ34428768-B15E9D23-DFB5-4406-A690-B8B7B1959E54Q34738282-40E1B966-145D-4E17-86D6-C973DE497058Q34992608-1207C635-5A35-4F81-80A1-A11C9FB7464FQ35089521-EC6BF7F9-8B12-44BA-98DC-0D2E4FD74D83Q35158162-1F18211D-90BB-4C82-B064-30A08675139EQ35204411-E2743DB0-F724-4C51-AB95-E541C3CA0ED4Q35987674-29C03B96-44E7-405E-B9ED-523D2C366000Q36007212-CA3B6A5C-029F-4D33-ABFA-440482AB708DQ36110734-1E8BBDA4-B059-42E1-A12C-41C43B2E2577Q36164883-A0783FE6-52A9-4C6A-83AB-7E7ACD237DDEQ36312718-33FCAFDC-4914-425C-9422-E3807524C29DQ36366228-C75E4D9F-45DF-4506-8AE1-054873E7991FQ36541370-0F3627AA-27F6-4756-BF4B-55C7ACA6BDFEQ36929420-857522E1-36B2-4B6F-B56F-2A2E2BC47622Q37071317-360431E5-891E-4158-ACEC-54C699F2DFF1Q37076538-CD428B14-51D3-47C1-ADC7-CEA6723C221AQ37226719-17DBDD42-74D1-4712-8DF5-CBF29B7CF162Q38111810-F8126F5D-2A65-4DD6-92D1-B1CE5F009443Q38165746-9CD20F6A-13C5-4C4C-9761-A2401EB96EEAQ38963714-725C7714-D582-4B6A-8C24-DF879C5DE4C4Q39225594-5C21E425-A90A-4772-9E35-19E3F767936BQ43560661-83E2F17E-ADE1-4328-A041-6CB1F04FC01DQ47943130-A113F073-1DA7-4356-B896-3F2B02628722Q55471916-2EAF936F-EBD5-4415-89EB-13DDA102FAEC
P2860
P2Y13 receptor is critical for reverse cholesterol transport
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
P2Y13 receptor is critical for reverse cholesterol transport
@ast
P2Y13 receptor is critical for reverse cholesterol transport
@en
P2Y13 receptor is critical for reverse cholesterol transport
@nl
type
label
P2Y13 receptor is critical for reverse cholesterol transport
@ast
P2Y13 receptor is critical for reverse cholesterol transport
@en
P2Y13 receptor is critical for reverse cholesterol transport
@nl
prefLabel
P2Y13 receptor is critical for reverse cholesterol transport
@ast
P2Y13 receptor is critical for reverse cholesterol transport
@en
P2Y13 receptor is critical for reverse cholesterol transport
@nl
P2093
P3181
P356
P1433
P1476
P2Y13 receptor is critical for reverse cholesterol transport
@en
P2093
Abduelhakem Ben Addi
Aurélie C Fabre
Bernard Robaye
Bertrand Perret
Camille Malaval
Céline Verdier
François Briand
Guillaume Combes
Laeticia Lichtenstein
Laurent O Martinez
P304
P3181
P356
10.1002/HEP.23897
P407
P577
2010-10-01T00:00:00Z